Oesch-Tox Toxicological Consulting and Expert Opinions, 55263, Ingelheim, Germany.
Institute of Toxicology, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Arch Toxicol. 2022 Sep;96(9):2573-2587. doi: 10.1007/s00204-022-03322-1. Epub 2022 Jun 15.
Methyl acrylate (MA) and ethyl acrylate (EA) had previously tested positive for mutagenicity in vitro, but in vivo studies were negative. One of the metabolism pathways of alkyl acrylates is conjugation with glutathione. The glutathione availability is restricted in standard in vitro test systems so that they do not reflect the in vivo metabolism in this respect. We investigated whether the addition of glutathione to the in vitro L5178Y/TK mouse lymphoma mutagenicity test prevents alkyl acrylate's mutagenicity in vitro. We also investigated whether the quantitative relationships support the notion that the GSH supplemented in vitro systems reflect the true in vivo activity. Indeed, glutathione concentrations as low as 1 mM completely negate the mutagenicity of MA and EA in the L5178Y/TK mouse lymphoma mutagenicity test up to the highest concentrations of the two acrylates tested, 35 µg/ml, a higher concentration than that previously found to be mutagenic in this test (14 µg MA/ml and 20 µg EA/ml). 1 mM Glutathione reduced the residual MA and EA at the end of the exposure period in the mutagenicity tests by 96-97%, but in vivo up to 100 mg/kg body weight MA and EA left the glutathione levels in the mouse liver and forestomach completely intact. It is concluded that the in-situ levels of glutathione, 7.55 ± 0.57 and 2.84 ± 0.22 µmol/g mouse liver and forestomach, respectively, can efficiently protect against MA and EA-induced mutagenicity up to the high concentration of 100 mg MA and EA/kg body weight and that the negative in vivo mutagenicity tests on MA and EA reflect the true in vivo situation.
甲基丙烯酸酯(MA)和乙基丙烯酸酯(EA)先前在体外测试中呈阳性,具有致突变性,但体内研究结果为阴性。烷基丙烯酸盐的一种代谢途径是与谷胱甘肽结合。谷胱甘肽在标准的体外测试系统中的可用性受到限制,因此它们不能反映在这方面的体内代谢。我们研究了向体外 L5178Y/TK 小鼠淋巴瘤致突变性测试中添加谷胱甘肽是否可以防止烷基丙烯酸盐的体外致突变性。我们还研究了定量关系是否支持这样的观点,即补充谷胱甘肽的体外系统反映了真正的体内活性。事实上,谷胱甘肽浓度低至 1mM 就可以完全消除 MA 和 EA 在 L5178Y/TK 小鼠淋巴瘤致突变性测试中的致突变性,直至测试的两种丙烯酸盐的最高浓度,35µg/ml,这一浓度高于以前在该测试中发现的致突变浓度(14µg MA/ml 和 20µg EA/ml)。在致突变试验中,1mM 谷胱甘肽使暴露期结束时试验中的剩余 MA 和 EA 减少了 96-97%,但在体内,高达 100mg/kg 体重的 MA 和 EA 使小鼠肝脏和前胃中的谷胱甘肽水平完全保持不变。因此,体内谷胱甘肽水平(分别为 7.55±0.57 和 2.84±0.22µmol/g 小鼠肝脏和前胃)可以有效地保护免受 MA 和 EA 诱导的致突变性,直至 100mg MA 和 EA/kg 体重的高浓度,MA 和 EA 的阴性体内致突变性测试反映了真实的体内情况。